Financial Performance - The company's operating revenue for Q1 2022 was ¥70,161,169.01, representing a decrease of 25.62% compared to the same period last year[5] - The net profit attributable to shareholders was -¥264,962.75, a decline of 101.57% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥1,100,943.45, down 106.72% from the previous year[5] - The net cash flow from operating activities was ¥2,401,025.22, a significant decrease of 89.29% compared to the same period last year[5] - Total operating revenue for Q1 2022 was ¥70,161,169.01, a decrease of 25.5% compared to ¥94,328,782.60 in Q1 2021[21] - Net profit for Q1 2022 was a loss of ¥264,962.75, compared to a net profit of ¥16,877,832.16 in Q1 2021, indicating a significant decline[23] - The company received cash from sales of ¥65,263,960.55 in Q1 2022, down from ¥108,645,235.02 in Q1 2021, indicating a decline in sales performance[26] - The basic and diluted earnings per share were both -¥0.0015, reflecting a decline of 101.15% year-on-year[6] - The basic and diluted earnings per share for Q1 2022 were both -¥0.0015, compared to ¥0.13 in Q1 2021, reflecting a downturn in profitability[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥759,861,900.82, a decrease of 2.65% from the end of the previous year[6] - As of March 31, 2022, the company's total assets amounted to ¥759,861,900.82, a decrease from ¥780,518,511.86 at the end of 2021, reflecting a decline of approximately 2.4%[16] - The company's current assets totaled ¥295,874,404.47, down from ¥351,220,180.59, indicating a decrease of about 15.7%[17] - The company's non-current assets totaled ¥463,987,496.35, an increase from ¥429,298,331.27, indicating a growth of about 8.1%[18] - The total liabilities included accounts payable of ¥23,221,103.57, down from ¥28,032,168.25, indicating a decrease of approximately 17.5%[18] - The company’s total liabilities decreased to ¥75,571,731.44 in Q1 2022 from ¥96,192,197.82 in Q1 2021, a reduction of 21.4%[20] - The total equity attributable to shareholders was ¥684,290,169.38 in Q1 2022, compared to ¥684,326,314.04 in Q1 2021, indicating stability in shareholder equity[20] Cash Flow - The company reported a cash flow from operating activities of ¥2,401,025.22 in Q1 2022, down from ¥22,411,790.25 in Q1 2021[27] - The net cash flow from investing activities was -$32,239,636.89, an improvement from -$41,096,069.61 in the previous year[28] - Cash inflow from financing activities totaled $61,529,971.19, with a net cash flow of -$15,000,000.00 compared to $25,416,859.46 in the prior year[29] - The net increase in cash and cash equivalents was -$44,981,492.45, contrasting with an increase of $7,375,562.16 in the previous year[29] - The ending balance of cash and cash equivalents was $85,233,978.41, down from $130,215,470.86 at the beginning of the period[29] - The company received cash from investment income amounting to $102,360.27, up from $94,472.21 year-over-year[28] - Total cash inflow from investment activities was $32,602,360.27, compared to $25,255,674.76 in the previous year[28] - Cash outflow for the acquisition of fixed assets and intangible assets was $36,841,997.16, down from $59,351,744.37 year-over-year[28] - The company paid $15,000,000.00 for debt repayment, a decrease from $35,200,000.00 in the previous year[29] - The impact of exchange rate changes on cash and cash equivalents was -$142,880.78, compared to a positive impact of $642,982.06 in the previous year[29] Research and Development - Research and development expenses totaled ¥4,738,347.74, accounting for 6.75% of operating revenue, an increase of 1.98 percentage points year-on-year[6] - Research and development expenses for Q1 2022 were ¥4,738,347.74, slightly up from ¥4,500,584.47 in Q1 2021, showing a focus on innovation[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,403[11] Other Information - The company experienced a decline in revenue due to delays in orders from major subsidiaries[9] - The company has not disclosed any new product developments or market expansion strategies in the current report[15] - The company did not apply the new accounting standards for the current year, indicating a continuation of previous accounting practices[29]

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 50,479,049.29 in 2021[6]. - The profit distribution plan for 2021 is to not distribute profits, which has been approved by the board of directors[6]. - The company's operating revenue for 2021 was CNY 379,186,008.35, representing a year-over-year increase of 20.92% compared to CNY 313,595,097.19 in 2020[22]. - The net profit attributable to shareholders for 2021 was CNY 50,479,049.29, which is a 7.96% increase from CNY 46,758,480.63 in 2020[22]. - The net profit after deducting non-recurring gains and losses was CNY 48,097,549.31, reflecting a 16.55% increase from CNY 41,267,768.61 in 2020[22]. - The cash flow from operating activities for 2021 was CNY 40,750,098.39, a significant decrease from CNY 91,092,991.60 in 2020[22]. - The total assets at the end of 2021 were CNY 780,518,511.86, which is a 38.22% increase from CNY 564,682,033.71 at the end of 2020[22]. - The net assets attributable to shareholders increased by 58.62% to CNY 684,326,314.04 at the end of 2021, compared to CNY 431,424,854.36 at the end of 2020[22]. - The basic earnings per share for 2021 was CNY 0.3401, down 5.21% from CNY 0.3588 in 2020[23]. - The diluted earnings per share for 2021 was also CNY 0.3401, reflecting the same decrease of 5.21% from the previous year[23]. - The weighted average return on equity for 2021 was 9.33%, a decrease of 1.81 percentage points from 11.14% in 2020[23]. Risk Management - There are no significant risks that materially affect the company's operations during the reporting period[4]. - The company has disclosed potential risks related to forward-looking statements in its report[4]. - The company has a comprehensive risk description in the management discussion and analysis section[4]. - The company has not yet achieved profitability since its listing[4]. - The company has not violated decision-making procedures for external guarantees[4]. - There are no non-operational fund occupations by controlling shareholders or related parties[4]. Research and Development - The company continued to increase R&D investment, with R&D expenses accounting for 6.27% of operating revenue, a decrease of 0.51 percentage points year-on-year[24]. - Research and development expenses amounted to 23.7789 million yuan, a year-on-year increase of 11.77%, with 41 new patents obtained during the reporting period[34]. - The company has developed a high-performance seawater desalination membrane with a target water flux greater than 30 GFD and a salt rejection rate exceeding 99.8%[74]. - The company is investing $30 million in research and development for new technologies aimed at enhancing product offerings[161]. - The company has increased its R&D personnel from 72 to 82, representing 16.87% of the total workforce, up from 14.69%[83]. Market Expansion and Sales - The company achieved operating revenue of 379.186 million yuan, an increase of 20.92% year-on-year, and a net profit attributable to shareholders of 50.479 million yuan, up 7.96% year-on-year[34]. - The company has established four regional sales centers in China to enhance domestic market promotion and brand building, optimizing market structure and customer base[35]. - The company is actively pursuing market expansion through new product development and strategic partnerships in various sectors, including seawater desalination and industrial wastewater treatment[76]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share by 2025[161]. - The company improved its marketing capabilities, leading to significant growth in domestic market coverage and sales revenue[110]. Governance and Compliance - The board of directors consists of 8 members, including 3 independent directors, and held 7 meetings during the reporting period[147]. - The supervisory board is composed of 3 members, including 1 employee supervisor, and convened 6 meetings in the reporting period[147]. - The company has established performance evaluation and incentive mechanisms for directors, supervisors, and senior management[148]. - The company strictly adhered to information disclosure obligations, ensuring that all disclosed information was true, accurate, complete, timely, and fair[148]. - The company has maintained a transparent and independent governance structure, with no interference from the controlling shareholder in operational decisions[149]. Financial Position and Assets - The total assets of the company increased to 3 billion, up from 2.5 billion, indicating a growth of 20% in asset value[163]. - Cash and cash equivalents at the end of the period amounted to ¥130,748,392.19, representing 16.75% of total assets, a significant increase of 628.44% compared to the previous period[126]. - Accounts receivable increased by 32.75% year-on-year to ¥82,424,457.27, reflecting the company's expanded revenue scale[127]. - Inventory increased by 32.73% year-on-year to ¥84,629,748.43, driven by rising raw material prices and expanded revenue scale[127]. - The company's fixed assets net value increased by 22.34% year-on-year to ¥199,008,681.04, due to the completion of construction projects[128]. Challenges and Risks - The company faces risks related to technological upgrades, as its competitive advantage relies on continuous innovation in high-performance membrane technology; failure to adapt could lead to a decline in market position and profitability[90]. - The company is currently developing new product lines based on long-term strategic planning, but risks include potential delays in R&D progress or failure to meet commercialization expectations[91]. - The company has a high proportion of overseas sales, which exposes it to risks from trade protectionism and geopolitical instability that could negatively impact international market demand[92]. - Rising prices of key raw materials such as fiberglass and epoxy resin have adversely affected the company's cost control and gross margin stability[92]. - The company faces financial risks related to accounts receivable, as an increase in outstanding balances could lead to potential collection issues and impact overall performance[95].

Financial Performance - The company's operating revenue for Q3 2021 was ¥83,924,729.29, representing a year-on-year increase of 6.99%[4] - The net profit attributable to shareholders for Q3 2021 was ¥10,245,812.53, a decrease of 9.76% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥9,510,028.82, down 4.44% year-on-year[4] - Total operating revenue for the first three quarters of 2021 reached ¥275,088,004.24, an increase from ¥218,216,547.24 in the same period of 2020, representing a growth of approximately 26%[19] - Net profit for the third quarter of 2021 was ¥41,272,531.91, compared to ¥29,169,388.00 in the same quarter of 2020, reflecting a growth of approximately 42%[20] - The total comprehensive income attributable to the parent company for Q3 2021 was CNY 41,120,253.92, compared to CNY 28,799,182.59 in Q3 2020, representing an increase of approximately 43%[21] - Basic and diluted earnings per share for Q3 2021 were CNY 0.29, up from CNY 0.22 in Q3 2020, reflecting a growth of about 31.82%[21] Assets and Liabilities - The total assets at the end of the reporting period reached ¥772,131,570.91, an increase of 36.74% compared to the end of the previous year[5] - The company's total assets as of the third quarter of 2021 amounted to ¥772,131,570.91, up from ¥564,682,033.71 in the previous year, marking an increase of about 37%[18] - The company's total liabilities decreased to ¥96,412,735.81 in the third quarter of 2021 from ¥133,257,179.35 in the previous year, a reduction of about 28%[17] - Current assets totaled ¥343,158,556.40 in the third quarter of 2021, compared to ¥223,935,914.48 in the same period of 2020, representing a growth of approximately 54%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 6,810[11] - The largest shareholder, Weisaibo Environmental Materials Holdings Limited, holds 60.79% of shares, totaling 105,630,070 shares[11] - The company has a total of 4,343,860 shares held under a strategic asset management plan with a 12-month lock-up period[13] - The company’s stock has been lent out, with 407,800 shares borrowed under margin trading, leaving a balance of 3,936,060 shares[13] Research and Development - Research and development expenses totaled ¥6,473,341.99, accounting for 7.71% of operating revenue, an increase of 0.75 percentage points[5] - Research and development expenses for the first three quarters of 2021 were ¥17,767,727.12, compared to ¥15,321,251.39 in 2020, indicating an increase of approximately 16%[19] Cash Flow - The cash flow from operating activities for the year-to-date period decreased by 56.89%, totaling ¥32,539,588.45[4] - Cash inflow from operating activities for the first nine months of 2021 was CNY 285,387,416.45, compared to CNY 236,708,227.71 in the same period of 2020, indicating an increase of approximately 20.5%[26] - Net cash flow from operating activities for the first nine months of 2021 was CNY 32,539,588.45, down from CNY 75,479,530.64 in the same period of 2020, showing a decline of about 57%[26] - Cash outflow from investing activities for the first nine months of 2021 totaled CNY 248,142,549.74, compared to CNY 99,023,498.52 in the same period of 2020, representing an increase of approximately 150.8%[27] - Net cash flow from financing activities for the first nine months of 2021 was CNY 183,478,531.76, compared to a negative cash flow of CNY 24,639,515.16 in the same period of 2020, indicating a significant turnaround[27] - The ending cash and cash equivalents balance as of September 30, 2021, was CNY 52,261,094.54, compared to CNY 38,558,208.36 at the end of Q3 2020, reflecting an increase of approximately 35.5%[27] Market Outlook - The company experienced a significant recovery in sales volume and gross margin as the impact of the pandemic gradually diminished[9] - The company plans to continue expanding its market presence and enhancing its product offerings in response to the recovering demand[9] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[20] Other Information - The company has not reported any significant new product developments or market expansions in the current quarter[14] - There are no significant mergers or acquisitions reported during the period[14] - The company has not provided specific future guidance or performance outlook in the current report[14] - The company experienced a foreign exchange loss of CNY 87,349.15 in Q3 2021, compared to a loss of CNY 740,261.29 in Q3 2020, indicating improved currency stability[27]

Financial Performance - The company reported a significant increase in revenue for the first half of 2021, achieving a total of 1.2 billion RMB, representing a growth of 25% year-over-year[1]. - The company's operating revenue for the first half of 2021 was ¥191,163,274.95, representing a 36.76% increase compared to ¥139,775,294.93 in the same period last year[25]. - The net profit attributable to shareholders for the first half of 2021 was ¥31,026,719.38, a 74.15% increase from ¥17,815,844.38 year-on-year[28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 94.74%, reaching ¥29,309,205.73 compared to ¥15,050,358.61 in the previous year[28]. - The basic earnings per share for the first half of 2021 was ¥0.24, up 71.43% from ¥0.14 in the previous year[27]. - The weighted average return on equity increased by 2.66 percentage points to 6.94% compared to 4.28% in the same period last year[27]. - The company attributed its revenue growth to the gradual recovery from the pandemic and increased market sales efforts[28]. Market Expansion and Strategy - The company has set a future outlook with a revenue target of 2.5 billion RMB for the full year 2021, which would represent a 30% increase from 2020[1]. - The company is expanding its market presence, targeting new regions in Southeast Asia, with plans to establish two new offices by the end of 2021[1]. - A strategic acquisition of a local competitor is in progress, which is anticipated to increase market share by 10%[1]. - The company aims to become an international leader in membrane separation technology, leveraging its proprietary technology and core intellectual property[33][40]. - The company is focusing on enhancing its market presence through strategic investments and potential acquisitions in the environmental technology sector[100]. Research and Development - The total R&D investment for the period was ¥11,294,385.13, representing a 14.58% increase compared to the previous period's ¥9,857,619.36[66]. - The company has established a comprehensive R&D system focused on developing new membrane materials and composite material equipment, driven by market demand and application goals[55]. - The company has successfully developed and can mass-produce 4 types of reverse osmosis membrane elements, with over 30 product specifications to meet diverse customer needs[44]. - The company has improved its production efficiency and product performance through ongoing process technology improvements and new product development[58]. - The company is committed to ongoing research and development to improve membrane performance and efficiency[70]. Product Development and Innovation - New product development includes the launch of a next-generation filtration system, expected to enhance efficiency by 20%[1]. - The company has developed a new membrane material with a water flux of ≥600 LMH/bar and a surface pore size of ≤50 nm, targeting municipal wastewater treatment[69]. - The company has completed the development of a new filter cartridge that integrates multiple filtration functions, enhancing user experience and product efficiency[71]. - The company is focusing on expanding its market presence by launching new products, including a combined water purification and coffee capsule machine, targeting diverse consumer needs[72]. - The integration of advanced filtration technologies is expected to improve market competitiveness and capture a larger market share[73]. Compliance and Risk Management - The report emphasizes the importance of compliance with regulatory requirements and the commitment to transparency in financial reporting[1]. - The company has identified potential risks in its operations and has outlined measures to mitigate these risks in the management discussion section of the report[1]. - The company faced risks related to high overseas sales proportion, with potential impacts from trade protectionism and geopolitical instability affecting international market demand[88]. - There is a risk of intensified market competition, particularly in reverse osmosis and nanofiltration membranes, which could affect market share and profitability if the company fails to maintain its technological edge[89]. - The company is exposed to risks from potential technology leaks and intellectual property violations, which could undermine its competitive advantage in the membrane separation technology industry[87]. Environmental and Social Responsibility - The company has implemented various pollution control measures, achieving compliance with environmental standards, including a dust emission of 6.00 tons per annum[112]. - The company has reported a total of 102,579.93 tons of wastewater discharge, which meets the municipal sewage discharge standards[112]. - The company has achieved a reduction in VOC emissions to 52.27 tons per annum, adhering to local regulatory requirements[112]. - The company emphasizes continuous innovation in providing advanced new material products to enhance energy conservation and emission reduction for downstream users[115]. Shareholder and Corporate Governance - The company has established a commitment to disclose any changes in shareholding status in a timely manner[123]. - The company will ensure timely reporting of any changes in shareholding by its directors and senior management[126]. - The company has outlined a three-year shareholder return plan post-IPO, focusing on sustainable and stable dividend decisions[150]. - The company plans to distribute cash dividends amounting to no less than 10% of the distributable profits attributable to shareholders in the consolidated financial statements for each of the next three years[152]. - The controlling shareholder has committed to not interfering in the company's management and to take necessary measures to mitigate the dilution of immediate returns[149].

Financial Performance - The company reported a total revenue of 1.5 billion RMB for the first half of 2021, representing a year-on-year increase of 20%[1]. - In the first half of 2021, the company's operating income reached ¥191,163,274.95, representing a 36.76% increase compared to ¥139,775,294.93 in the same period last year[24]. - The net profit attributable to shareholders increased by 74.15% to ¥31,026,719.38 from ¥17,815,844.38 year-on-year[27]. - The net profit after deducting non-recurring gains and losses rose by 94.74% to ¥29,309,205.73 compared to ¥15,050,358.61 in the previous year[27]. - Basic earnings per share increased by 71.43% to ¥0.24 from ¥0.14 in the previous year[26]. - The weighted average return on equity rose to 6.94%, an increase of 2.66 percentage points from 4.28% year-on-year[26]. - The company's cash flow from operating activities decreased by 20.55% to ¥35,789,839.57, attributed to increased strategic inventory and higher personnel costs[27]. - The gross profit margin improved to 35%, up from 30% in the same period last year, reflecting better cost management[1]. - The company achieved a revenue of 2,000,000.0 RMB in the first half of 2021, with a net profit of 589,960.73 RMB, representing a significant increase compared to the previous period[73]. - The company reported a total revenue of 26,300,000.00 RMB for the period, with a significant increase in net profit to 6,738,983.00 RMB[75]. Research and Development - Investment in R&D increased by 30% compared to the previous year, focusing on advanced membrane technology and environmental solutions[1]. - The company has introduced a new line of eco-friendly products, projected to contribute an additional 200 million RMB in revenue by year-end[1]. - The company has established a comprehensive R&D system focused on developing new membrane materials and composite material equipment, guided by application goals and market demands[57]. - The company has developed a new anti-fouling coating technology that maintains stable flux and desalination rates, with a current investment of ¥3,200,000 and cumulative investment of ¥764,253.46[70]. - The company has successfully developed and can mass-produce 4 types of reverse osmosis membrane elements, with over 30 product specifications available to meet diverse customer needs[45]. - The company has achieved a desalination rate of 99.4% for its new product, with a stable water production capacity of 41 m³/d[72]. - The company is currently working on projects with a total expected investment of ¥5,000,000, with a current investment of ¥611,018.14 and cumulative investment of ¥3,443,309.1, focusing on improving desalination membrane technology[70]. - The company has reported R&D expenses of ¥11,294,385.13 for the first half of 2021, up 14.6% from ¥9,857,619.36 in the same period last year[197]. Market Expansion and Strategy - The company expects a revenue growth forecast of 25% for the second half of 2021, driven by new product launches and market expansion strategies[1]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2022[1]. - A strategic acquisition of a local competitor is in progress, expected to enhance the company's production capacity by 40%[1]. - The company is focusing on expanding its market presence in various industries, including steel and chemical sectors, through innovative membrane materials[71]. - The company is exploring potential mergers and acquisitions to enhance its technological capabilities and market reach[72]. - The company is committed to continuous improvement and innovation in its product offerings to maintain a competitive edge in the industry[72]. Environmental Responsibility - Environmental measures have been implemented, resulting in a reduction of dust emissions to 6.00 tons per annum, compliant with national standards[115]. - The company reported SO2 emissions of 0.38 tons per annum and VOCs emissions of 52.27 tons per annum, adhering to local environmental standards[116]. - The production wastewater generated amounted to 102,579.93 tons per annum, meeting the second-level discharge standards[116]. - The company has implemented various pollution prevention measures to mitigate dust, gas, and noise pollution during production[118]. - The company is committed to providing advanced new material products to enhance energy-saving and emission-reduction levels in downstream industries[118]. - The company has a long-term commitment to environmental responsibility and pollution prevention[118]. Shareholder Commitments and Governance - The company reported a commitment to not transfer or manage shares held prior to the stock issuance for 36 months, ensuring stability in shareholding[124]. - The actual controller of the company, Xie Jian, expressed confidence in the company's business prospects and plans to hold shares long-term[127]. - The company has committed to not proposing share buybacks for shares held prior to the issuance during the lock-up period[126]. - The company emphasizes compliance with the regulations set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange regarding shareholding[127]. - The company has established a commitment to support its business development and maintain a long-term holding strategy for its shares[127]. - The company will ensure that any share sales by major shareholders will not violate their commitments[135]. - The company commits to ensuring the accuracy and completeness of its IPO prospectus, bearing legal responsibility for any misrepresentation[146]. Risk Management - The company has identified potential risks related to supply chain disruptions and is implementing measures to mitigate these risks[1]. - The company faced risks related to high overseas sales proportion, with potential impacts from trade protectionism and geopolitical instability affecting international market demand[91]. - There is a risk of intensified market competition, particularly in reverse osmosis and nanofiltration membranes, which could affect market share and profitability if the company fails to maintain its technological edge[92]. - The financial expenses increased significantly due to exchange rate fluctuations and higher interest costs, with a reported financial loss of approximately ¥1.89 million compared to a gain in the previous year[97].